Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide in Asian T2DM Patients Insufficiently Controlled with Basal Insulin
NCT00866658Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2009
- Primary completion
- Jun 2010
- Modality
- Peptides
- Countries
- 4
01
Overview
A Phase 3 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Mar 2009; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00866658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866658.